Where Will Novo Nordisk Go Next?
Once high-flying on the strength of Ozempic and Wegovy, pharmaceutical major Novo Nordisk (NYSE:NVO) has seen its shares slide more than 50 percent over the …
Eli Lilly and Co
Is Viking Therapeutics Stock a Bargain?
Viking Therapeutics (NASDAQ:VKTX) is a pharmaceutical startup whose stock has gone through substantial ups and downs over the last several years. While VKTX …
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and will probably mushroom for the foreseeable future. Despite the fact that these drugs have only been …
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech sector has been the driving engine of America’s stock market. Investors have piled into the largest …
Is PFE the Best Dividend Play in Its Industry?
By their inherent nature, established pharma companies face a demand backdrop that is stable because consumers rarely cut medical spending, even in tough …
Is Eli Lilly Stock Undervalued?
Eli Lilly (NYSE:LLY) is one of the major pharmaceutical companies that has come to dominate the market for GLP-1 anti-obesity drugs. As the maker of Mounjaro …
Is Amgen Stock a Safe Bet in the Biotech Industry?
The biotech market is expanding steadily as new technology makes previously impossible medical breakthroughs a reality. Global biotech is forecasted to reach …
3 Weight-Loss Stocks to Buy Now
Since the release of Ozempic and its weight-loss counterpart for labeled use, Wegovy, the stock market has enthusiastically been buying companies involved in …
Is Hims & Hers the Next Big Healthcare Stock? Here’s How High It Could Climb
Telehealth company Hims & Hers (NYSE:HIMS) is familiar to most consumers from the virtual ubiquity of its radio, TV and online advertising. Operating as a …
Where Will Veeva Systems Stock Be in 10 Years?
Veeva Systems (NYSE:VEEV), a software solutions provider for the life sciences industry, has seen some weakness amid the slowdown in cloud market demand as …
VOO vs QQQ: Which ETF Is Best?
Exchange-traded funds continue to dominate investors’ portfolios for good reason, they give buyers exposure to a wide range of assets and avoid …
Is Berkshire Better Than S&P 500?
Exchange-traded funds and mutual funds that track the S&P 500 have been the bedrock of countless portfolios. These investment vehicles allow buyers to …
Is Amgen Stock a Buy?
Amgen Inc. (NASDAQ:AMGN) stock has been on an uptrend lately. The favorable price action can be attributed to encouraging outcomes from its injectable obesity …
Should I Buy VOO or SPY?
Exchange-traded funds reached global assets under management of $11.5 trillion in 2023, a 25% year-over-year increase. While ETFs can be built to track the …
Is AbbVie The Perfect Dividend Stock For Retirees?
Retirees have typically turned to investment vehicles that are stable and relatively safe, such as bonds or CDs. Because of the stock market’s volatility, …
Is Any Company Worth $1 Trillion?
A $1 trillion market capitalization seemed like an unattainable benchmark just 30 years ago, yet now it’s not a matter of who but how many companies have …
Is it Too Late to Buy Eli Lilly Stock?
Pharmaceutical major Eli Lilly (NYSE:LLY) has seen its stock rise by more than 110% over the past 12 months, allowing it to handily beat the market in what was …
How High Will Viking Therapeutics Stock Go?
The latest clinical trials reported by Viking Therapeutics sparked huge interest amid the growing hype around anti-obesity drugs, but how high can the stock …
Is it Too Late to Buy LLY Stock?
Eli Lilly (NYSE:LLY) has been on an impressive run lately. The pharmaceutical stock has gained 77% in the last year and achieved record highs of over $635 …
3 Magnificent Dividend Stocks to Buy Hand Over Fist
The market rally in the first half of 2023 saw the S&P 500 up over 20% by July. But the fall season checked the bullish momentum and brought the …